| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics, Inc. | Puissance Capital Fund (GP) LLC | 10% Owner | Oct 13, 2023 | Sale | $0.10 | 1,076,841 | 111,776 | 0 | Oct 16, 2023, 08:51 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Puissance Capital Management LP | 10% Owner | Jun 07, 2023 | Sale | $0.83 | 134,421 | 111,569 | 1,076,841 | Jun 07, 2023, 09:21 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Kim Bobae | VP Reg. Affairs & Quality | May 18, 2023 | Option Exercise | $9.70 | 10,743 | 104,170 | 1,723 | May 22, 2023, 06:51 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Puissance Life Science Opportunities Fund VI | 10% Owner | May 18, 2023 | Sale | $9.46 | 560,000 | 5,297,600 | 1,211,262 | May 19, 2023, 08:55 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Dekker Martin | VP OF ENGINEERING & MANUFACTUR | Dec 09, 2022 | Option Exercise | $0.93 | 7,834 | 7,286 | 17,666 | Dec 13, 2022, 05:26 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Parag Suresh | VP OF BUSINESS OPERATIONS | Dec 09, 2022 | Option Exercise | $0.93 | 7,834 | 7,286 | 17,666 | Dec 13, 2022, 05:25 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Laccona Nicholas | FINANCIAL OFFICER, (PFO & PAO) | Dec 09, 2022 | Option Exercise | $0.93 | 5,530 | 5,143 | 12,470 | Dec 13, 2022, 05:25 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Fernandes Peter | PRINCIPAL EXECUTIVE OFFICER | Dec 09, 2022 | Option Exercise | $0.93 | 9,985 | 9,287 | 22,515 | Dec 13, 2022, 05:25 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Puissance Capital Management (GP) LLC | 10% Owner | Jun 07, 2021 | Option Exercise | $4.00 | 8,189 | 32,756 | 1,771,262 | Jun 08, 2021, 12:37 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | KLINSKY STEVEN B | 10% Owner | Mar 18, 2021 | Sale | $5.48 | 400,000 | 2,192,000 | 609,231 | Mar 22, 2021, 09:36 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | FARES Wassim | Chief Medical Officer | Sep 10, 2020 | Buy | $10.18 | 4,000 | 40,708 | 4,000 | Sep 14, 2020, 08:31 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | Jun 05, 2020 | Buy | $12.72 | 4,986 | 63,442 | 58,313 | Jun 09, 2020, 04:01 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | Jun 08, 2020 | Buy | $12.87 | 2,600 | 33,454 | 60,913 | Jun 09, 2020, 04:01 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Puissance Capital Management (GP) LLC | 10% Owner | May 21, 2020 | Option Exercise | $13.00 | 1,153,846 | 14,999,998 | 1,153,846 | May 22, 2020, 07:25 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | Nov 21, 2019 | Buy | $0.37 | 200 | 74 | 584,679 | Nov 25, 2019, 04:52 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | Nov 22, 2019 | Buy | $0.37 | 1,050 | 394 | 585,729 | Nov 25, 2019, 04:52 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | Nov 25, 2019 | Buy | $0.39 | 7,193 | 2,774 | 592,922 | Nov 25, 2019, 04:52 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Parag Suresh | VP of Business Operations | Nov 15, 2019 | Option Exercise | $0.34 | 25,993 | 8,838 | 105,606 | Nov 19, 2019, 04:36 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Fernandes Peter | Chief Regulatory & Safety Offr | Nov 15, 2019 | Option Exercise | $0.34 | 40,280 | 13,695 | 182,022 | Nov 19, 2019, 04:36 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Tenenbaum Fabian | Chief Executive Officer | Nov 15, 2019 | Option Exercise | $0.34 | 76,823 | 26,120 | 407,459 | Nov 19, 2019, 04:36 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Dekker Martin | VP of Engineering & Manuf | Nov 15, 2019 | Option Exercise | $0.34 | 27,134 | 9,226 | 124,619 | Nov 19, 2019, 04:35 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Korner Assaf | CFO | Nov 15, 2019 | Option Exercise | $0.34 | 32,987 | 11,216 | 66,078 | Nov 19, 2019, 04:35 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Nimish P | 10% Owner | Oct 24, 2019 | Sale | $0.50 | 704,595 | 353,354 | 6,824,425 | Oct 28, 2019, 05:17 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Co-Investment Holdings III, LLC | 10% Owner | Oct 25, 2019 | Sale | $0.45 | 56,242 | 25,511 | 6,768,183 | Oct 28, 2019, 05:17 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Management III, LLC | 10% Owner | Oct 28, 2019 | Sale | $0.44 | 333,010 | 146,091 | 6,435,173 | Oct 28, 2019, 05:17 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Venrock Management IV, LLC | 10% Owner | Oct 24, 2019 | Sale | $0.50 | 704,595 | 353,354 | 6,824,425 | Oct 28, 2019, 05:15 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Co-Investment Holdings II, LLC | 10% Owner | Oct 25, 2019 | Sale | $0.45 | 56,242 | 25,511 | 6,768,183 | Oct 28, 2019, 05:15 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Oct 28, 2019 | Sale | $0.44 | 333,010 | 146,091 | 6,435,173 | Oct 28, 2019, 05:15 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | Jun 12, 2019 | Buy | $0.64 | 50,000 | 31,905 | 584,479 | Jun 14, 2019, 11:46 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | May 22, 2019 | Buy | $0.60 | 27,500 | 16,533 | 534,479 | May 24, 2019, 09:30 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Edmonds Amy | VP Clinical Operations & Admin | May 22, 2019 | Option Exercise | $0.61 | 35,827 | 21,797 | 140,216 | May 23, 2019, 04:46 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | May 21, 2019 | Buy | $0.61 | 43,280 | 26,371 | 506,979 | May 22, 2019, 11:15 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | Director | May 21, 2019 | Buy | $0.61 | 20,000 | 12,198 | 1,875,920 | May 22, 2019, 11:14 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Tenenbaum Fabian | Chief Executive Officer | May 21, 2019 | Buy | $0.60 | 5,000 | 2,975 | 484,282 | May 22, 2019, 11:14 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Nimish P | 10% Owner | Jan 23, 2019 | Buy | $0.70 | 142,857 | 100,000 | 7,529,020 | Mar 14, 2019, 05:57 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Jan 23, 2019 | Buy | $0.70 | 142,857 | 100,000 | 7,529,020 | Mar 14, 2019, 05:51 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Director | Jan 25, 2019 | Buy | $0.70 | 450,000 | 315,000 | 463,699 | Jan 25, 2019, 04:22 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | Director | Jan 25, 2019 | Buy | $0.70 | 714,286 | 500,000 | 1,855,920 | Jan 25, 2019, 04:21 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Amin Naseem | Director | Jan 25, 2019 | Buy | $0.70 | 571,429 | 400,000 | 1,818,867 | Jan 25, 2019, 04:12 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Management III, LLC | 10% Owner | Sep 14, 2018 | Buy | $1.23 | 75,000 | 92,250 | 7,326,163 | Sep 17, 2018, 04:46 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Management III, LLC | 10% Owner | Sep 17, 2018 | Buy | $1.18 | 60,000 | 70,944 | 7,386,163 | Sep 17, 2018, 04:46 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Nimish P | 10% Owner | Sep 13, 2018 | Buy | $1.19 | 75,000 | 89,160 | 7,251,163 | Sep 17, 2018, 04:46 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Venrock Partners, L.P. | 10% Owner | Sep 13, 2018 | Buy | $1.19 | 75,000 | 89,160 | 7,251,163 | Sep 17, 2018, 04:42 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Co-Investment Holdings II, LLC | 10% Owner | Sep 14, 2018 | Buy | $1.23 | 75,000 | 92,250 | 7,326,163 | Sep 17, 2018, 04:42 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Venrock Management IV, LLC | 10% Owner | Sep 17, 2018 | Buy | $1.18 | 60,000 | 70,944 | 7,386,163 | Sep 17, 2018, 04:42 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Sep 12, 2018 | Buy | $1.15 | 750,000 | 859,125 | 7,176,163 | Sep 12, 2018, 12:00 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Sep 11, 2018 | Buy | $1.14 | 1,000,000 | 1,144,200 | 7,101,163 | Sep 12, 2018, 12:00 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Sep 12, 2018 | Buy | $1.15 | 375,000 | 429,562 | 7,176,163 | Sep 12, 2018, 12:00 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Sep 10, 2018 | Buy | $1.22 | 2,000,000 | 2,436,400 | 6,901,163 | Sep 12, 2018, 12:00 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Sep 11, 2018 | Buy | $1.14 | 2,000,000 | 2,288,400 | 7,101,163 | Sep 12, 2018, 12:00 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ASSOCIATES IV L P | 10% Owner | Sep 10, 2018 | Buy | $1.22 | 1,000,000 | 1,218,200 | 6,901,163 | Sep 12, 2018, 12:00 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Koh Bong Y | 10% Owner | Sep 05, 2018 | Buy | $0.85 | 50,000 | 42,325 | 6,591,163 | Sep 07, 2018, 05:45 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Management II, LLC | 10% Owner | Sep 06, 2018 | Buy | $0.84 | 50,000 | 42,095 | 6,641,163 | Sep 07, 2018, 05:45 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ENTREPRENEURS FUND IV L P | 10% Owner | Sep 07, 2018 | Buy | $0.90 | 60,000 | 53,742 | 6,701,163 | Sep 07, 2018, 05:45 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Management III, LLC | 10% Owner | Sep 06, 2018 | Buy | $0.84 | 50,000 | 42,095 | 6,641,163 | Sep 07, 2018, 05:42 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Co-Investment Holdings III, LLC | 10% Owner | Sep 07, 2018 | Buy | $0.90 | 60,000 | 53,742 | 6,701,163 | Sep 07, 2018, 05:42 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Management III, LLC | 10% Owner | Sep 05, 2018 | Buy | $0.85 | 50,000 | 42,325 | 6,591,163 | Sep 07, 2018, 05:42 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Nimish P | 10% Owner | Aug 14, 2018 | Buy | $0.65 | 190,977 | 123,868 | 6,202,770 | Aug 16, 2018, 07:33 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Nimish P | 10% Owner | Aug 15, 2018 | Buy | $0.65 | 272,000 | 175,902 | 6,474,770 | Aug 16, 2018, 07:33 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Nimish P | 10% Owner | Aug 16, 2018 | Buy | $0.65 | 66,393 | 43,109 | 6,541,163 | Aug 16, 2018, 07:33 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VENROCK ENTREPRENEURS FUND IV L P | 10% Owner | Aug 16, 2018 | Buy | $0.65 | 66,393 | 43,109 | 6,541,163 | Aug 16, 2018, 07:31 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Management II, LLC | 10% Owner | Aug 14, 2018 | Buy | $0.65 | 190,977 | 123,868 | 6,202,770 | Aug 16, 2018, 07:31 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | VHCP Co-Investment Holdings II, LLC | 10% Owner | Aug 15, 2018 | Buy | $0.65 | 272,000 | 175,902 | 6,474,770 | Aug 16, 2018, 07:31 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Quinn Deborah | Chief Medical Officer | Jun 12, 2018 | Option Exercise | $2.37 | 10,541 | 24,982 | 94,070 | Jun 14, 2018, 04:42 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Parag Suresh | VP Proj Mgmt & Distribution | Jun 12, 2018 | Option Exercise | $2.37 | 7,144 | 16,931 | 53,094 | Jun 14, 2018, 04:41 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Edmonds Amy | VP Clinical Operations & Admin | Jun 12, 2018 | Option Exercise | $2.37 | 7,499 | 17,773 | 93,800 | Jun 14, 2018, 04:40 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Tenenbaum Fabian | Chief Executive Officer | Jun 12, 2018 | Option Exercise | $2.37 | 63,486 | 150,462 | 254,983 | Jun 14, 2018, 04:39 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Fernandes Peter | Chief Regulatory & Safety Offr | Jun 12, 2018 | Option Exercise | $2.37 | 11,304 | 26,790 | 102,676 | Jun 14, 2018, 04:37 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Dekker Martin | VP of Engineering & Manuf | Jun 12, 2018 | Option Exercise | $2.37 | 7,473 | 17,711 | 69,510 | Jun 14, 2018, 04:35 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Fernandes Peter | Chief Regulatory & Safety Offr | Jan 04, 2018 | Option Exercise | $2.49 | 35,321 | 87,949 | 82,453 | Jan 08, 2018, 05:26 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Parag Suresh | VP Proj Mgmt & Distribution | Jan 04, 2018 | Option Exercise | $2.49 | 23,180 | 57,718 | 39,548 | Jan 08, 2018, 04:52 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Dekker Martin | VP of Engineering & Manuf | Jan 04, 2018 | Option Exercise | $2.49 | 24,284 | 60,467 | 55,308 | Jan 08, 2018, 04:49 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Quinn Deborah | Chief Medical Officer | Jan 04, 2018 | Option Exercise | $2.49 | 33,114 | 82,454 | 75,054 | Jan 08, 2018, 04:46 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Schoeps Megan | Principal Financial Officer | Dec 13, 2017 | Option Exercise | $0.49 | 1,000 | 490 | 19,248 | Dec 13, 2017, 04:36 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Schoeps Megan | Principal Financial Officer | May 17, 2017 | Option Exercise | $1.40 | 10,459 | 14,683 | 18,248 | May 19, 2017, 04:04 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Luehring Jens | Director | Dec 09, 2016 | Buy | $0.56 | 20,000 | 11,200 | 39,860 | Dec 12, 2016, 10:10 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Quinn Deborah | Chief Medical Officer | Sep 12, 2016 | Option Exercise | $1.38 | 18,548 | 25,596 | 31,244 | Sep 13, 2016, 08:21 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Shah Parag Suresh | VP Proj Mgmt & Distribution | Sep 12, 2016 | Option Exercise | $1.38 | 4,673 | 6,449 | 8,881 | Sep 13, 2016, 08:18 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Dekker Martin | VP of Device Engineering | Sep 12, 2016 | Option Exercise | $1.38 | 13,333 | 18,400 | 23,181 | Sep 13, 2016, 08:16 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Edmonds Amy | VP Clinical Operations & Admin | Sep 12, 2016 | Option Exercise | $1.38 | 13,301 | 18,355 | 23,213 | Sep 13, 2016, 08:14 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Fernandes Peter | Chief Regulatory Officer | Sep 12, 2016 | Option Exercise | $1.38 | 19,785 | 27,303 | 35,722 | Sep 13, 2016, 08:11 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | President and CEO | May 17, 2016 | Buy | $1.37 | 5,000 | 6,841 | 222,702 | May 18, 2016, 01:46 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | President and CEO | Dec 15, 2015 | Buy | $2.72 | 7,500 | 20,400 | 38,927 | Dec 17, 2015, 05:01 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | President and CEO | Dec 16, 2015 | Buy | $2.76 | 12,800 | 35,336 | 51,727 | Dec 17, 2015, 05:01 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | President and CEO | Aug 19, 2015 | Buy | $5.48 | 5,000 | 27,377 | 31,427 | Aug 20, 2015, 05:34 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | MEGLASSON MARTIN | Chief Scientific Officer | May 20, 2015 | Buy | $8.40 | 712 | 5,981 | 19,098 | May 22, 2015, 07:32 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | President and CEO | May 20, 2015 | Buy | $8.69 | 5,560 | 48,323 | 26,427 | May 22, 2015, 07:32 AM | |
| BLPH | Bellerophon Therapeutics, Inc. | ARCH VENTURE PARTNERS VI LP | 10% Owner | Feb 19, 2015 | Buy | $12.00 | 212,666 | 2,551,992 | 965,660 | Feb 23, 2015, 09:48 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | NELSEN ROBERT | Director | Feb 19, 2015 | Buy | $12.00 | 212,666 | 2,551,992 | 965,660 | Feb 23, 2015, 09:47 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | New Mountain Partners II Special (AIV-A) LP | 10% Owner | Feb 19, 2015 | Buy | $12.00 | 1,070,166 | 12,841,992 | 4,859,885 | Feb 23, 2015, 09:47 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Weinstein Adam | Director | Feb 19, 2015 | Buy | $12.00 | 1,070,166 | 12,841,992 | 4,859,885 | Feb 23, 2015, 09:47 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Holt Matthew S. | Director | Feb 19, 2015 | Buy | $12.00 | 1,070,166 | 12,841,992 | 4,859,885 | Feb 23, 2015, 09:46 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Linde North America, Inc. | 10% Owner | Feb 19, 2015 | Buy | $12.00 | 358,916 | 4,306,992 | 1,629,804 | Feb 23, 2015, 09:41 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Luehring Jens | Director | Feb 19, 2015 | Buy | $12.00 | 358,916 | 4,306,992 | 1,629,804 | Feb 23, 2015, 09:41 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Tasse Daniel | Director | Feb 19, 2015 | Buy | $12.00 | 25,000 | 300,000 | 128,898 | Feb 23, 2015, 09:41 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Heyrman Reinilde | Chief Clinical Dev. Officer | Feb 19, 2015 | Buy | $12.00 | 1,500 | 18,000 | 9,483 | Feb 23, 2015, 09:40 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | MEGLASSON MARTIN | Chief Scientific Officer | Feb 19, 2015 | Buy | $12.00 | 12,000 | 144,000 | 18,386 | Feb 23, 2015, 09:39 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Naidu Manesh | Chief Business Officer | Feb 19, 2015 | Buy | $12.00 | 1,500 | 18,000 | 11,319 | Feb 23, 2015, 09:39 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | President and CEO | Feb 19, 2015 | Buy | $12.00 | 20,800 | 249,600 | 20,867 | Feb 23, 2015, 09:39 PM |
Menu